Wealth Enhancement Advisory Services’s Oramed Pharmaceuticals ORMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41K | Buy |
18,799
+5,000
| +36% | +$10.9K | ﹤0.01% | 3221 |
|
|
2025
Q1 | $29.5K | Hold |
13,799
| – | – | ﹤0.01% | 2857 |
|
|
2024
Q4 | $33.4K | Buy |
13,799
+2,499
| +22% | +$6.05K | ﹤0.01% | 2845 |
|
|
2024
Q3 | $27.6K | Sell |
11,300
-100
| -0.9% | -$244 | ﹤0.01% | 2592 |
|
|
2024
Q2 | $29.3K | Hold |
11,400
| – | – | ﹤0.01% | 2451 |
|
|
2024
Q1 | $33.3K | Sell |
11,400
-500
| -4% | -$1.46K | ﹤0.01% | 2343 |
|
|
2023
Q4 | $27.5K | Hold |
11,900
| – | – | ﹤0.01% | 2224 |
|
|
2023
Q3 | $31.1K | Buy |
+11,900
| New | +$31.1K | ﹤0.01% | 2149 |
|